| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |